spacer
spacer

PDBsum entry 4jsj

Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Oxidoreductase/oxidoreductase inhibitor PDB id
4jsj

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
407 a.a.
Ligands
HEM ×2
H4B ×2
ACT ×2
QJ7 ×2
Metals
_ZN
Waters ×366
PDB id:
4jsj
Name: Oxidoreductase/oxidoreductase inhibitor
Title: Structure of rat neuronal nitric oxide synthase heme domain in complex with 6-(((5-(((3-fluorophenethyl)amino)methyl)pyridin-3-yl)oxy) methyl)-4-methylpyridin-2-amine
Structure: Nitric oxide synthase, brain. Chain: a, b. Fragment: heme domain (unp residues 297-718). Synonym: bnos, constitutive nos, nc-nos, nos type i, neuronal nos, n- nos, nnos, peptidyl-cysteine s-nitrosylase nos1. Engineered: yes
Source: Rattus norvegicus. Rat. Organism_taxid: 10116. Gene: nos1, bnos. Expressed in: escherichia coli. Expression_system_taxid: 469008.
Resolution:
1.92Å     R-factor:   0.195     R-free:   0.225
Authors: H.Li,T.L.Poulos
Key ref: Q.Jing et al. (2013). In search of potent and selective inhibitors of neuronal nitric oxide synthase with more simple structures. Bioorg Med Chem Lett, 21, 5323-5331. PubMed id: 23867386 DOI: 10.1016/j.bmc.2013.06.014
Date:
22-Mar-13     Release date:   07-Aug-13    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P29476  (NOS1_RAT) -  Nitric oxide synthase 1 from Rattus norvegicus
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1429 a.a.
407 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.1.14.13.39  - nitric-oxide synthase (NADPH).
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: 2 L-arginine + 3 NADPH + 4 O2 + H+ = 2 L-citrulline + 2 nitric oxide + 3 NADP+ + 4 H2O
2 × L-arginine
+ 3 × NADPH
+ 4 × O2
+ H(+)
= 2 × L-citrulline
+ 2 × nitric oxide
+ 3 × NADP(+)
+ 4 × H2O
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1016/j.bmc.2013.06.014 Bioorg Med Chem Lett 21:5323-5331 (2013)
PubMed id: 23867386  
 
 
In search of potent and selective inhibitors of neuronal nitric oxide synthase with more simple structures.
Q.Jing, H.Li, J.Fang, L.J.Roman, P.Martásek, T.L.Poulos, R.B.Silverman.
 
  ABSTRACT  
 
In certain neurodegenerative diseases damaging levels of nitric oxide (NO) are produced by neuronal nitric oxide synthase (nNOS). It, therefore, is important to develop inhibitors selective for nNOS that do not interfere with other NOS isoforms, especially endothelial NOS (eNOS), which is critical for proper functioning of the cardiovascular system. While we have been successful in developing potent and isoform-selective inhibitors, such as lead compounds 1 and 2, the ease of synthesis and bioavailability have been problematic. Here we describe a new series of compounds including crystal structures of NOS-inhibitor complexes that integrate the advantages of easy synthesis and good biological properties compared to the lead compounds. These results provide the basis for additional structure-activity relationship (SAR) studies to guide further improvement of isozyme selective inhibitors.
 

 

spacer

spacer